The clinical significance of the increased IL-10 levels in COVID-19 patients has been interpreted as an immune-inhibitory negative feedback tool triggered by the rapidly increasing pro-inflammatory mediators (64, 65) and an attempt to prevent tissue damage (60). This evidence concerns the gene IL10 and COVID-19.